Evidence map›Paper›PMID 29523397›Full record

ReviewTransfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis2018

0.9% NaCl (Normal Saline) - Perhaps not so normal after all?

Neil Blumberg, Jill M Cholette, Anthony P Pietropaoli, Richard Phipps, Sherry L Spinelli, Michael P Eaton, Suzie A Noronha, Jerard Seghatchian, Joanna M Heal, Majed A Refaai

Abstract readReview
In one paragraph

Review in Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 61 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. How do we forecast tomorrow's transfusion? Prehospital transfusion.Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine · 2023
    Article
  15. In Vitro Biodegradation of a-C:H:SiOMaterials (Basel, Switzerland) · 2022
    Article
  16. Article
  17. Viability ofVeterinary world · 2022
    Article
  18. Article
  19. Article
  20. Prehospital Plasma Transfusion: What Does the Literature Show?Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Neil BlumbergDepartment of Pathology and Laboratory Medicine (Transfusion Medicine), University of Rochester Medical Center, Rochester, NY, USA. Electronic address: neil_blumberg@urmc.rochester.edu.
Jill M CholetteDepartment of Pediatrics (Critical Care and Cardiology), University of Rochester Medical Center, Rochester, NY (USA), USA.
Anthony P PietropaoliDepartment of Medicine (Critical Care and Pulmonary), University of Rochester Medical Center, Rochester, NY, USA.
Richard PhippsDepartments of Environmental Medicine, Medicine and Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA.
Sherry L SpinelliDepartment of Pathology and Laboratory Medicine (Transfusion Medicine), University of Rochester Medical Center, Rochester, NY, USA.
Michael P EatonDepartment of Anesthesiology, University of Rochester Medical Center, Rochester, NY, USA.
Suzie A NoronhaDepartment of Pediatrics (Hematology-Oncology), University of Rochester Medical Center, Rochester, NY, USA.
Jerard SeghatchianInternational Consultancy in Blood Components Quality/Safety Improvement, Audit/Inspection and DDR Strategies, London, UK.
Joanna M HealDepartment of Pathology and Laboratory Medicine (Transfusion Medicine), University of Rochester Medical Center, Rochester, NY, USA; Department of Medicine (Hematology-Oncology), University of Rochester Medical Center, Rochester, NY, USA.
Majed A RefaaiDepartment of Pathology and Laboratory Medicine (Transfusion Medicine), University of Rochester Medical Center, Rochester, NY, USA; Department of Medicine (Hematology-Oncology), University of Rochester Medical Center, Rochester, NY, USA.
University of Rochester Medical Center · US

Funding

Identification and Significance of Biologic Mediators in Red Cell ConcentratesR01HL095467 · NHLBI · UNIVERSITY OF ROCHESTER · PI BLUMBERG, NEIL, PHIPPS, RICHARD P. · 2009 to 2012
$1.5M
NHLBI NIH HHS R01 HL095467
6 · The paper itself

Abstract

Crystalloid infusion is widely employed in patient care for volume replacement and resuscitation. In the United States the crystalloid of choice is often normal saline. Surgeons and anesthesiologists have long preferred buffered solutions such as Ringer's Lactate and Plasma-Lyte A. Normal saline is the solution most widely employed in medical and pediatric care, as well as in hematology and transfusion medicine. However, there is growing concern that normal saline is more toxic than balanced, buffered crystalloids such as Plasma-Lyte and Lactated Ringer's. Normal saline is the only solution recommended for red cell washing, administration and salvage in the USA, but Plasma-Lyte A is also FDA approved for these purposes. Lactated Ringer's has been traditionally avoided in these applications due to concerns over clotting, but existing research suggests this is not likely a problem. In animal models and clinical studies in various settings, normal saline can cause metabolic acidosis, vascular and renal function changes, as well as abdominal pain in comparison with balanced crystalloids. The one extant randomized trial suggests that in very small volumes (2 l or less) normal saline is not more toxic than other crystalloids. Recent evidence suggests that normal saline causes substantially more in vitro hemolysis than Plasma-Lyte A and similar solutions during short term storage (24 hours) after washing or intraoperative salvage. There are now abundant data to raise concerns as to whether normal saline is the safest replacement solution in infusion therapy, red cell washing and salvage, apheresis and similar uses. In the USA, Plasma-Lyte A is also FDA approved for use with blood components and is likely a safer solution for these purposes. Its only disadvantage is a higher cost. Additional studies of the safety of normal saline for virtually all current clinical uses are needed. It seems likely that normal saline will eventually be abandoned in favor of safer, more physiologic crystalloid solutions in the coming years.

Indexed as

AdolescentAnimalsChildChild, PreschoolElectrolytesFemaleHumansInfantIsotonic SolutionsMaleRinger's LactateSodium ChlorideElectrolytesIsotonic SolutionsPlasmalyte ARinger's LactateSodium ChlorideCrystalloidHemolysisResuscitationSalineTransfusion

Identifiers

PMID29523397
PMCPMC5899644
OpenAlexW2791701127

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.